Rocuronium Injection, Solution
Product Images NDC 65219-697

This is a description for a medication with National Drug Code 65219-442-02. It is a sterile, nonpyrogenic paralyzing agent in a single-dose vial, containing Rocuronium Bromide. The medication is intended for intravenous use only and requires facilities to have artificial respiration readily available due to the risk of respiratory arrest. It contains inactive ingredients like hydrochloric acid and sodium chloride, with a specific dosage mentioned in the Prescribing Information. This medication should be stored at temperatures between 20°C to 25°C and should not be frozen.*

This text describes a medication called Rocuronium Bromide Injection, which is a paralyzing agent used for intravenous administration only. Each single-dose vial contains 50 mg of Rocuronium Bromide, with a concentration of 10 mg per mL. The medication is sterile and nonpyrogenic. It is important to have facilities available for artificial respiration as the medication can cause respiratory arrest. The dosage information is provided in the Prescribing Information. The medication should be stored at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F), and it should not be frozen. The container closure is latex-free. The manufacturer of the medication is Fresenius Kabi based in Lake Zurich, IL.*

This text is a label for a medication with the NDC code 65219-444-04, which is described as a sterile, nonpyrogenic solution in a single-dose vial. The medication is Rocuronium, a paralyzing agent used for inducing muscular relaxation during surgeries. It warns about causing respiratory arrest and the need for immediate availability of facilities for artificial respiration. The dosage information and storage conditions are also provided, highlighting that it should be kept between 20°C to 25°C.ROC 3167-09*

NDC 65219-444-10 is a sterile, nonpyrogenic paralyzing agent called Rocuronium Bromide Injection used for causing respiratory arrest. Facilities must have artificial respiration available. Each mL contains 10 mg Rocuronium Bromide (equivalent to 8.69 mg rocuronium) along with other ingredients. The dosage information can be found in the Prescribing Information. Store between 20°C to 25°C (68°F to 77°F) and avoid freezing. This product is for intravenous use only. The container closure is not made with natural rubber latex. Unused portions should be discarded. From Fresenius Kabi, in Lake Zurich, IL 60047.*

This is a description of a medication with the National Drug Code (NDC) 65219-695-01. It is a sterile, nonpyrogenic solution containing Rocuronium Bromide, a paralyzing agent used to induce muscle relaxation. The text provides warnings about respiratory arrest and the need for immediate availability of facilities for artificial respiration in case of overdose. It also includes information on the dosage and storage conditions for the medication. The manufacturer is Fresenius Kabi based in Lake Zurich, IL.*

This is a description of Rocuronium Bromide Injection, a medication used as a paralyzing agent for intravenous use. Each 5 mL vial contains 50 mg of Rocuronium Bromide, with a concentration of 10 mg per mL. This medication should only be administered by healthcare professionals with facilities for artificial respiration readily available due to respiratory arrest risk. The inactive ingredients include hydrochloric acid and sodium chloride to adjust pH levels. Storage should be between 20°C and 25°C, with excursions allowed between 15°C and 30°C. The container closure does not contain natural rubber latex. Manufactured by Fresenius Kabi in Lake Zurich, IL.*

This text contains information regarding a sterile, nonpyrogenic paralyzing agent, Rocuronium Injection. It warns about causing respiratory arrest and provides details on the contents of each mL, storage instructions, and dosages. It emphasizes that it is for intravenous use only and must not be frozen. Additionally, it alerts facilities to have artificial respiration available and provides temperature storage guidelines.*

This is a description of a medication with the National Drug Code 65219-697-10 intended for prescription use only. It contains Rocuronium Bromide, a paralyzing agent that can cause respiratory arrest and artificial respiration may be necessary. The solution is sterile and nonpyrogenic, with each mL containing 10 mg of Rocuronium Bromide. The medication should be stored at a temperature range between 20°C to 25°C and should not be frozen. The packaging is specified to be single-dose vials by Fresenius Kabi. The container closure is not made with natural rubber latex. Additional information and dosing guidelines can be found in the Prescribing Information.*

This is a label for Rocuronium Bromide Injection, a paralyzing agent used for intravenous use only. Each milliliter contains 10 mg of Rocuronium Bromide. The instructions indicate to peel off and apply the medication. The text also states "Rx only", suggesting it is for prescription use only.*